We offer a complete integrated solution for the development and manufacturing of lateral flow assays and reader systems.
Developing the next generation of rapid diagnostic products to meet the market need for simple to use, rapid, cost effective, portable systems.
Rapid diagnostic device for the quantitative measurement of kappa (K) and lambda (λ) immunoglobulin free light chains (FLCs).
See how our assay development team can deliver your lateral flow assay to market on time and on budget.… https://t.co/XzoZOdiLME
20 July 2018
© Abingdon Health 2018